GL9I Stock Overview
Operates as a nutrition company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Glanbia plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €15.64 |
| 52 Week High | €18.36 |
| 52 Week Low | €15.44 |
| Beta | 0.51 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 12.00% |
| 5 Year Change | 46.40% |
| Change since IPO | 170.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| GL9I | GB Food | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | 2.2% |
| 1Y | n/a | 5.2% | 8.0% |
Return vs Industry: Insufficient data to determine how GL9I performed against the UK Food industry.
Return vs Market: Insufficient data to determine how GL9I performed against the UK Market.
Price Volatility
| GL9I volatility | |
|---|---|
| GL9I Average Weekly Movement | n/a |
| Food Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GL9I's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine GL9I's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 5,534 | Hugh McGuire | www.glanbia.com |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Glanbia plc Fundamentals Summary
| GL9I fundamental statistics | |
|---|---|
| Market cap | €3.73b |
| Earnings (TTM) | €282.41m |
| Revenue (TTM) | €4.25b |
13.2x
P/E Ratio0.9x
P/S RatioIs GL9I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GL9I income statement (TTM) | |
|---|---|
| Revenue | US$4.47b |
| Cost of Revenue | US$3.27b |
| Gross Profit | US$1.20b |
| Other Expenses | US$906.60m |
| Earnings | US$297.30m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.16 |
| Gross Margin | 26.94% |
| Net Profit Margin | 6.65% |
| Debt/Equity Ratio | 44.0% |
How did GL9I perform over the long term?
See historical performance and comparison